NEO Jeffrey Scott Sherman buys $150K worth of shares
May 07, 2025, 4:34 AM
0.00%
What does NEO do
NeoGenomics, a clinical laboratory company based in Fort Myers, Florida, specializes in cancer genetics diagnostic testing and pharma services, employing 2,100 staff since its IPO in December 2012. Its services include clinical cancer testing and advanced diagnostics for healthcare providers and pharmaceutical companies.
Jeffrey Scott Sherman bought 20,000 shares of NEO on 2 May at $7.51 per share, worth a total of $150K. They now own 158,494 NEO shares, or a 14% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.